Nancy A. Grygiel - 16 Mar 2026 Form 4 Insider Report for AMGEN INC (AMGN)

Role
SVP & CCO
Signature
/s/ Nancy A. Grygiel
Issuer symbol
AMGN
Transactions as of
16 Mar 2026
Net transactions value
$0
Form type
4
Filing time
18 Mar 2026, 20:34:15 UTC
Previous filing
05 Mar 2026
SEC
View on sec.gov

Reporting Owners (1)

Name Relationship Address Signature Signature date CIK
Grygiel Nancy A. SVP & CCO ONE AMGEN CENTER DRIVE, THOUSAND OAKS /s/ Nancy A. Grygiel 16 Mar 2026 0001816414

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction AMGN Common Stock Tax liability -787 -8.5% $366.21* 8,488 16 Mar 2026 Direct F1
holding AMGN Common Stock 106 16 Mar 2026 401(k) Plan F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 These shares include 122 Dividend Equivalents (DEs) granted pursuant to the Amgen Inc. Second Amended and Restated 2009 Equity Incentive Plan and subject to a qualifying dividend reinvestment plan. DEs are credited to the reporting person's unvested Restricted Stock Units and are paid out in shares of the Company's common stock on a one-to-one basis according to the vesting schedule, along with a cash payment for any remaining fractional share amount.
F2 These are shares acquired under the Company's 401(k) Plan and represent interests in the Company's stock fund as of this filing.